Quote: If tonight's CC only deals in very broad ge
Post# of 30028
Posted On: 09/02/2014 1:06:13 PM
Re: Daveludlow #5247
Quote: If tonight's CC only deals in very broad generalities for revenue guidance, and no bridge test data is discussed....and no business developments regarding LymPro can be discussed,...the pps won't ignite.
GC already said 'qualitative' revenue guidance so it will be broad and not have many, or any, numbers attached. He also specifically stated today they are in the process of completing the Bridge Study. You won't get numbers there today either. I think BP has been playing hardball and version 2, LPC backing, additional shares, and Icon agreement is his way if playing hard ball as well. Are you not happy with the fact we will have a revenue generating product in the next 12 weeks?
GC already said 'qualitative' revenue guidance so it will be broad and not have many, or any, numbers attached. He also specifically stated today they are in the process of completing the Bridge Study. You won't get numbers there today either. I think BP has been playing hardball and version 2, LPC backing, additional shares, and Icon agreement is his way if playing hard ball as well. Are you not happy with the fact we will have a revenue generating product in the next 12 weeks?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼